The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Take proper precautions and seek timely treatment!
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Subscribe To Our Newsletter & Stay Updated
